Human Immunodeficiency Virus Type 1 Evades T-Helper Responses by Exploiting Antibodies That Suppress Antigen Processing
Open Access
- 15 July 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (14) , 7645-7652
- https://doi.org/10.1128/jvi.78.14.7645-7652.2004
Abstract
T-helper responses are important for controlling chronic viral infections, yet T-helper responses specific to human immunodeficiency virus type 1 (HIV-1), particularly to envelope glycoproteins, are lacking in the vast majority of HIV-infected individuals. It was previously shown that the presence of antibodies to the CD4-binding domain (CD4bd) of HIV-1 glycoprotein 120 (gp120) prevents T-helper responses to gp120, but their suppressive mechanisms were undefined (C. E. Hioe et al., J. Virol. 75:10950-10957, 2001). The present study demonstrates that gp120, when complexed to anti-CD4bd antibodies, becomes more resistant to proteolysis by lysosomal enzymes from antigen-presenting cells such that peptide epitopes are not released and presented efficiently by major histocompatibility complex class II molecules to gp120-specific CD4 T cells. Antibodies to other gp120 regions do not confer this effect. Thus, HIV may evade anti-viral T-helper responses by inducing and exploiting antibodies that conceal the virus envelope antigens from T cells.Keywords
This publication has 37 references indexed in Scilit:
- HIV‐1–Infected Patients with Envelope‐Specific Lymphoproliferation or Long‐Term Nonprogression Lack Antibodies Suppressing Glycoprotein 120 Antigen PresentationThe Journal of Infectious Diseases, 2004
- Propagation of CD4+T Cells Specific for HIV Type 1 Envelope gp120 from Chronically HIV Type 1-Infected SubjectsAIDS Research and Human Retroviruses, 2003
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sitesNature, 2002
- Viral interference with antigen presentationNature Immunology, 2002
- High Levels of Antibodies to the CD4 Binding Domain of Human Immunodeficiency Virus Type 1 Glycoprotein 120 Are Associated with Faster Disease ProgressionThe Journal of Infectious Diseases, 2002
- Inhibition of Human Immunodeficiency Virus Type 1 gp120 Presentation to CD4 T Cells by Antibodies Specific for the CD4 Binding Domain of gp120Journal of Virology, 2001
- Anti-CD4-Binding Domain Antibodies Complexed with HIV Type 1 Glycoprotein 120 Inhibit CD4+T Cell-Proliferative Responses to Glycoprotein 120AIDS Research and Human Retroviruses, 2000
- Genetic Variation of HIV Type 1 in Four World Health Organization-Sponsored Vaccine Evaluation Sites: Generation of Functional Envelope (Glycoprotein 160) Clones Representative of Sequence Subtypes A, B, C, and EAIDS Research and Human Retroviruses, 1994
- Epitope-directed processing of specific antigen by B lymphocytes.The Journal of cell biology, 1989
- Enhanced stability against heat denaturation of E. coli wild type and mutant β-galactosidase in the presence of specific antibodiesBiochemical and Biophysical Research Communications, 1970